advertisement
Abstract #46400 Published in IGR 13-3
Current Prospects in Optic Nerve Protection and Regeneration: Sixth ARVO/Pfizer Ophthalmics Research Institute Conference
Limb GA; Martin KRInvestigative Ophthalmology and Visual Science 2011; 52: 5941-5954
The sixth annual conference of the ARVO/Pfizer Ophthalmic Research Institute was held in Fort Lauderdale, Florida, on April 30 and May 1, 2010. Funded by the ARVO Foundation for Eye Research through a grant from Pfizer Ophthalmics, the conference brought together several specialist scientists and clinicians in the fields of glaucoma, neural regeneration, gene therapy, and stem cell therapy to discuss current knowledge and formulate new strategies for the design and implementation of therapies to maintain, repair, and regenerate optic nerve function. The conference was divided into four main sessions, with themes introduced by a keynote presentation of 20 minutes, followed by a 10-minute discussion and then discussions on five to six topics. Each topic was introduced by a 5- to 7-minute overview by a specialist in the field who then led a 20-minute discussion. Each session was moderated by two experts in each area of discussion. These lively discussions were intended to identify the most important questions that are still unanswered or need further exploration. This report provides a synopsis of discussions and introduces guidelines for future research.
From the Institute of Ophthalmology, University College, London, and Moorfields Eye Hospital, UK.
Classification:
11.8 Neuroprotection (Part of: 11 Medical treatment)
2.17 Stem cells (Part of: 2 Anatomical structures in glaucoma)
11.9 Gene therapy (Part of: 11 Medical treatment)